MIDATECH PHARMA
News | News 2014
Dec 17, 2014
Midatech Pharma awarded EU grant funding to support training and research into glycan based multivalent immunotherapeutics

Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Dec 8, 2014
Midatech Pharma acquires Q Chip to support novel delivery platforms and product developments in cancer, diabetes and ophthalmology

Oxford, UK - Midatech Pharma PLC (AIM: MTPH, “Midatech” or the “Company”) is pleased to announce the completion of the... read more >

Dec 8, 2014
Admission and First Day of Dealings on AIM following £32 million Placing and Completion of Acquisition of Q Chip

Oxford, UK – Midatech, a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Nov 20, 2014
Midatech Pharma-led consortium selected for €7.9 million EU grant funding

Oxford, UK, 20 November 2014 – Midatech Pharma Ltd (“Midatech”) is pleased to announce that a consortium, led by Midatech, has... read more >

Sep 10, 2014
Midatech Biogune receives financial support from the Spanish Government:

Midatech Biogune, following the financing plan of the Ministry of Economy and Competition, through the program EQUIPA 2014, as laid down in... read more >

Jul 2, 2014
Midatech appoints Nick Robbins-Cherry as Finance Director

Abingdon, UK, 2 July 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

Jun 20, 2014
Midatech forms distinguished Neuro-Oncology Advisory Board

Abingdon, UK, 20 June 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

Jun 18, 2014
Positive Results from Phase I Clinical Study with MidaForm Insulin PharmaFilm® Presented at the American Diabetes Association

Abingdon, UK, 18 June 2014 – Midatech Ltd, a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

May 12, 2014
Midatech forms prestigious Scientific Advisory Board

Abingdon, UK, 12 May 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

May 6, 2014
Midatech wins grant funding from Spanish government

Abingdon, UK, 6 May 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

Apr 30, 2014
Midatech appoints Rolf Stahel as Chairman

Abingdon, UK, 30 April 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

 

News
News 2014
Dec 17, 2014
Midatech Pharma awarded EU grant funding to support training and research into glycan based multivalent immunotherapeutics

Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Dec 8, 2014
Midatech Pharma acquires Q Chip to support novel delivery platforms and product developments in cancer, diabetes and ophthalmology

Oxford, UK - Midatech Pharma PLC (AIM: MTPH, “Midatech” or the “Company”) is pleased to announce the completion of the... read more >

Dec 8, 2014
Admission and First Day of Dealings on AIM following £32 million Placing and Completion of Acquisition of Q Chip

Oxford, UK – Midatech, a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Nov 20, 2014
Midatech Pharma-led consortium selected for €7.9 million EU grant funding

Oxford, UK, 20 November 2014 – Midatech Pharma Ltd (“Midatech”) is pleased to announce that a consortium, led by Midatech, has... read more >

Sep 10, 2014
Midatech Biogune receives financial support from the Spanish Government:

Midatech Biogune, following the financing plan of the Ministry of Economy and Competition, through the program EQUIPA 2014, as laid down in... read more >

Jul 2, 2014
Midatech appoints Nick Robbins-Cherry as Finance Director

Abingdon, UK, 2 July 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

Jun 20, 2014
Midatech forms distinguished Neuro-Oncology Advisory Board

Abingdon, UK, 20 June 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

Jun 18, 2014
Positive Results from Phase I Clinical Study with MidaForm Insulin PharmaFilm® Presented at the American Diabetes Association

Abingdon, UK, 18 June 2014 – Midatech Ltd, a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

May 12, 2014
Midatech forms prestigious Scientific Advisory Board

Abingdon, UK, 12 May 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

May 6, 2014
Midatech wins grant funding from Spanish government

Abingdon, UK, 6 May 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

Apr 30, 2014
Midatech appoints Rolf Stahel as Chairman

Abingdon, UK, 30 April 2014 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on... read more >

© Copyright 2017 Midatech Pharma PLC